Related Experiment Videos
Comparative analysis of mononuclear cell surface markers in atopic processes--a preliminary study
Yonathan Garfias1, Enrique Rojas-Ramos, María del Carmen Jiménez
1Departamento de Bioquímica, Instituto Nacional de Enfermedades Respiratorias, Tlalpan, México.
Immunological Investigations
|May 2, 2003
Summary
Immune markers like CD30 on CD4+ T cells are elevated in atopic dermatitis, differing from other atopic conditions. This suggests distinct immune responses and CD30 may indicate disease activity.
Area of Science:
- Immunology
- Dermatology
- Allergy
Background:
- Atopic disorders are primarily mediated by T helper 2 (Th2) cells.
- Understanding immune cell marker expression is crucial for differentiating atopic diseases.
Purpose of the Study:
- To investigate the expression of costimulatory molecules and cell surface markers on immune cells in various atopic diseases.
- To correlate marker expression with disease severity in conditions like atopic dermatitis, asthma, and rhinitis.
Main Methods:
- Flow cytometry was used to analyze peripheral CD4+ T cells and antigen-presenting cells.
- Patient samples included those with atopic dermatitis, contact dermatitis, mild/severe asthma, and symptomatic/non-symptomatic atopic rhinitis.
Main Results:
- CD30, CD124, and CD152 expression on CD4+ T cells were significantly higher in atopic dermatitis compared to contact dermatitis.
- Unlike other atopic diseases, CD80 expression on T and B cells was not elevated in atopic dermatitis patients.
- Specific marker expression patterns suggest distinct immunological mechanisms underlying different atopic conditions.
Conclusions:
- Immune mechanisms vary across different atopic disorders.
- Elevated CD30 expression on CD4+ T cells may serve as a potential biomarker for atopic dermatitis activity.